THRX Financial Facts

Loss from operations: 27.92M
Research and development: 286K
See Full Income Statement

Accumulated other comprehensive income (loss): 8K
Deferred revenue: 2.44M
See Full Balance Sheet

Theravance Inc. (THRX) Earnings

  |   Expand Research on THRX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -408.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -2.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/7/24 Q423 N/A-$0.29 N/A N/AN/A N/A N/A N/A
11/27/23 Q323 N/A-$0.35 N/A N/AN/A N/A N/A N/A
11/20/23 Q323 N/A-$0.36 N/A N/AN/A N/A N/A N/A
11/13/23 Q323 N/A-$0.36 N/A N/AN/A N/A N/A N/A
8/10/23 Q223 -$0.34-$0.35 +$0.01N/AN/A N/A Details
5/11/23 Q123 -$0.34-$0.41 +$0.07N/AN/A N/A Details
3/9/23 Q422 N/A-$0.44 N/A N/AN/A N/A N/A N/A
11/3/22 Q322 -$0.24-$0.32 +$0.08N/AN/A N/A Details